David A. Orr, DO

NPI 1215016217ActiveIndividual· Internal Medicine, Pulmonary Disease· Hackensack, NJ

Internal Medicine, Pulmonary Disease (DO) in Hackensack, New Jersey, trained at Rowan University School of Osteopathic Medicine (class of 1987). Their prescriptions cost Medicare Part D more than their services did: $1,699,933 for 4,273 claims, against $212,983 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 26 companies reporting payments in 2025, $3,179 in all, mostly food and beverage.

Overview

NPI	1215016217
Status	Active
Entity type	Individual
Credential	DO
Sole proprietor	No
NPI issued	Nov 2, 2006
Last updated in NPPES	Jun 8, 2016

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	MB54395	NJ

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (NJ)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	698
Services billed	2,847 across 33 procedure codes
Paid by Medicare	$212,983

Part D prescriptions in 2024

Prescriptions (claims)	4,273 · 6,744 30-day fills
Patients	632
Total drug cost	$1,699,933
Generic share	54% of claims

Medicare sources and data years

Education and affiliations

Medical school	Rowan University School of Osteopathic Medicine
Graduation year	1987
Medicare specialty	Pulmonary Disease
Secondary specialties	Critical Care (Intensivists)